Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
25 participants
INTERVENTIONAL
2023-02-06
2024-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prospective, Explorative, Research Study with Women to Investigate Menstruation Leakage At Night
NCT06637787
Sleep Quality and the Menstrual Cycle
NCT06906133
The Effects of the Female Hormones on Cerebral Perfusion
NCT03299179
Sleep-wake Changes of Luteinizing Hormone Frequency in Pubertal Girls With and Without High Testosterone
NCT00930007
Depressive Symptoms and Subjective Stress in the Course of the Menstrual Cycle - an Ambulatory Assessment Study.
NCT04086316
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Women with reported heavy menses
Nighttime Feminine Product
During nights while menstruating:
* Standardized nighttime feminine product + typical nighttime behaviors to prevent leak
* Standardized nighttime feminine product + refraining from nighttime behaviors to prevent leak
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Nighttime Feminine Product
During nights while menstruating:
* Standardized nighttime feminine product + typical nighttime behaviors to prevent leak
* Standardized nighttime feminine product + refraining from nighttime behaviors to prevent leak
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Generally healthy (self-assessed; no significant underlying disease)
* Premenopausal patients with regular menstrual cycles every 21 to 35 days
* Patients with at least 3 days and no more than 7 days of bleeding during menstruation
* An intact uterus and at least one ovary
* Ability and willingness to provide written informed consent
* Willingness to adhere to study procedures
* Menstrual pads are the primary form for nighttime menstrual protection needs
* Will maintain a daily schedule that allows normal or typical sleep habits (ie, not a night-shift worker; \>5 hours of sleep).
* Women will self-report that they have heavy flow and perform at least one of the following compensatory behaviors:
* Set an alarm or plan to get up in the middle of the night to check or change the pad
* Add additional disposable absorbent products for extra leak protection of coverage (e.g. extra pads or liners)
* Use pillows or other means to limit sleep positions (to prevent moving at night)
* Use something extra on top of my bedding (such as a towel) to sleep on
* Wear an extra pair of pants/shorts
* Wear tighter clothing than they typically would, like yoga pants
Exclusion Criteria
* Any condition (social or medical) that, in the opinion of the primary care giver or study staff, would make trial participation unsafe or complicate data interpretation
* Difficult sleeping environment due to:
* Frequently involved in activities requiring nighttime awakenings (eg, taking care of an infant or loved one).
* Disruptive bed partners (i.e., snoring, children, pets, etc)
* Diagnosed sleep disorders (i.e. insomnia, sleep apnea, restless leg disorder, breathing disorder, etc)
* Use of an Intrauterine Device (IUDs) unless copper IUD.
* Regular use (\>1 day per week) of sleep aids and/or sedating medications, including over the counter products like melatonin.
18 Years
50 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Northwestern University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jessica Walter
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Dermatology, Northwestern University Feinberg School of Medicine
Chicago, Illinois, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STU00215465
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.